EUCTR2014-004760-37-FI进行中（未招募）不适用
Incretin-based therapy in non-symptomatic, early diagnosed type 1 diabetics - LiraT1D10-30
Riitta Veijola0 个研究点目标入组 10 人开始时间: 2015年12月21日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •The subjects are 10-30 years of age, have early diagnosis type 1 diabetes (no symptoms, diagnosis usually in OGTT), and are not pregnant.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 5
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 5
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Principal exclusion criteria are:
- •previous treatment in the last three months with any antidiabetic medication other than insulin
- •impaired liver or kidney function
- •past or current history of pancreatitis
- •serum calcitonin value above normal (>50 ng/l)
- •presence of any chronic metabolic, hematologic or malignant disease
- •obesity BMI =30
- •pregnancy
研究者
相似试验
进行中（未招募）
不适用
Incretin-based therapy in late preclinical type 1 diabetesType 1 diabetesEUCTR2014-004761-25-FIRiitta Veijola82
进行中（未招募）
不适用
Incretin-based therapy in preclinical type 1 diabetes in adults.MedDRA version: 18.1Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861Type 1 diabetesEUCTR2014-003667-37-FIRiitta Veijola
已完成
不适用
Incretin response in patients with idiopathic reactive hypoglycemiaidiopathic reactive hypoglycemiaJPRN-UMIN000007359Department of Endocrinology and Metabolism, Faculty of Medicine, University of Tsukuba15
进行中（未招募）
1 期
Efficacy of adjuvant Imatinib in patients with intermediate-risk gastrointestinal stromal tumor with a high-risk Genomic Grade Index. Multicenter, prospective, randomized study.Patients with intermediate-risk gastrointestinal stromal tumor presenting a high Genomic Grade IndexEUCTR2014-005255-87-FRAssistance Publique Hôpitaux de MARSEILLE80
进行中（未招募）
1 期
Efficacy of adjuvant Imatinib in patients with intermediate-risk gastrointestinal stromal tumor with a high-risk Genomic Grade Indexgastrointestinal stromal tumorCTIS2024-515432-71-00Centre Hospitalier Regional De Marseille80